A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients-Reference-Cited by-同舟云学术

A Fully Automated Method for the Determination of Serum Belatacept and Its Application in a Pharmacokinetic Investigation in Renal Transplant Recipients

Published:2019-02 Issue:1 Volume:41 Page:11-18
ISSN:0163-4356
Container-title:Therapeutic Drug Monitoring
language:en
Short-container-title:

Author:

Klaasen Rolf Anton,Egeland Erlend Johannessen,Chan Joe,Midtvedt Karsten,Svensson My,Bolstad Nils,Fellström Bengt,Holdaas Hallvard,Åsberg Anders,Bergan Stein,Vethe Nils Tore,Warren David John

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Pharmacology

Reference20 articles.

1. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study);Vincenti;Am J Transpl.,2010

2. A phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study);Durrbach;Am J Transpl.,2010

3. Belatacept and long-term outcomes in kidney transplantation;Vincenti;N Engl J Med.,2016

4. A randomized controlled clinical trial comparing belatacept with tacrolimus after de novo kidney transplantation;de Graav;Transplantation.,2017

5. Current practice for therapeutic drug monitoring of biopharmaceuticals in spondyloarthritis;Medina;Ther Drug Monit.,2017

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential for therapeutic drug monitoring of belatacept and other biologicals in solid organ transplantation;British Journal of Clinical Pharmacology;2024-07-26

2. Quantification of belatacept by liquid chromatography-tandem mass spectrometry in human plasma: Application to a pharmacokinetic study in renal transplant recipients;Clinical Biochemistry;2023-03

3. Humoral immune response to SARS-CoV-2 vaccination in patients with inflammatory bowel disease on immunosuppressive medication: association to serum drug levels and disease type;Scandinavian Journal of Gastroenterology;2023-02-14

4. Transplacental passage of belimumab during pregnancy and follow-up of a child exposed in utero;Annals of the Rheumatic Diseases;2023-01-05

5. Novel A-π-D-π-A type non-fullerene acceptors of dithienyl diketopyrropopyrrole derivatives to enhance organic photovoltaic applications: a DFT study;RSC Advances;2023